Shuttle Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $9 | $0 | $9 |
Gross Profit | -1 | 7 | ||
EBITDA | -3,510 | -1,599 | -1,382 | -1,280 |
EBIT | -3,511 | -1,600 | -1,384 | -1,282 |
Net Income | -3,784 | -2,031 | -1,731 | -1,640 |
Net Change In Cash | 0 | 9 | 0 | 9 |
Free Cash Flow | -1,998 | -1,399 | -1,239 | -1,043 |
Cash | 156 | 695 | 1,398 | 2,576 |
Basic Shares | 2,384 | 2,104 | 16,572 | 16,069 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -6 | -66 | -60 |
EBITDA | -5,885 | -4,319 | -1,040 |
EBIT | -5,892 | -4,325 | -1,101 |
Net Income | -6,592 | -3,099 | -1,202 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -5,600 | -2,710 | -300 |
Cash | 2,576 | 8,417 | 504 |
Basic Shares | 1,864 | 10,351 | 13,586 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.58 |
2024-06-30 | -$0.96 |
2024-03-31 | -$0.83 |
2023-12-31 | -$0.81 |
